VIM and metastatic malignant neoplasm in the lymph nodes: Additionally, high Vimentin expression was associated with poor DFS in patients with early pathological stage disease (I-II; AHR = 1.86; 95% CI = 1.13–3.08; p = 0.016, S5 Table) and in patients without lymph node metastasis (N0; AHR = 1.79; 95% CI = 1.11–2.88; p = 0.017, S5 Table).